<!DOCTYPE html>
<html lang="en">

<head>
    
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hogarth</title>

    <link rel="preconnect" href="https://fonts.gstatic.com">
    <link href="https://fonts.googleapis.com/css2?family=Roboto:ital,wght@0,100;0,300;0,400;0,500;0,700;0,900;1,100;1,300;1,400;1,500;1,700;1,900&display=swap" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.3/css/all.min.css"
    rel="stylesheet" />
    <link rel="stylesheet" href="css/normalize.css">
    <link rel="stylesheet" href="style.css">
    
    <script src="https://s0.2mdn.net/ads/studio/cached_libs/tweenmax_1.18.0_499ba64a23378545748ff12d372e59e9_min.js"></script>
</head>

<body>
    <header>
        <img class="fondoRojo" src="images/fondo-horizontal.jpg" alt="">
        <img class="headerBlanco" src="images/header-blanco.png" alt="">
        <a href=""><img class="icono" src="images/icono.png" alt=""></a>
        <a href=""><img class="logo" src="images/logo.png" alt=""></a>
    </header>

    <div class="vaccine">

        <div id="shingrix">
            SHINGRIX is a vaccineindicated for prevention of herpes <br>
            zoster (shingles) in adults 50 years and older. <br>
            SHINGRIX is not indicated for prevention of primary <br>
            varicella infection (chicken pox).
        </div>
        <div id="help">
            HELP ENSURE
        </div>
        <div id="they">
            THEY COME BACK
        </div>
        <div id="remind">
            REMIND PATIENTS TO <br>
            COMPLETE THE 2-DOSE SERIES <br>
            The second dose should be administrated <br>
            2 to 6 months after de first dose.
        </div>
        <div id="jeringa1">
            <img src="images/jeringa1.png" alt="">
        </div>
        <div id="jeringa2">
            <img src="images/jeringa2.png" alt="">
        </div>
        <div id="mas">
            <b>+</b>
        </div>
        <div id="learn">
            <b>LEARN MORE  <i class="fas fa-caret-right"></i></b> 
        </div>


    </div>

    <script>

        let tl = new TimelineLite;

        tl.to("#shingrix", 3, {
        opacity: 0,
        })
        .to("#help", 2, {
            opacity: 100
        })
        .to("#help", 2, {
            ease: "circ.out",
            opacity: 0
        })
        .to("#they", 2, {
            ease: "circ.out",
            opacity: 100
        })
        .to("#they", 2, {
            ease: "circ.out",
            opacity: 0
        })
        .to("#remind", 2, {
            ease: "circ.out",
            opacity: 100
        })
        .to("#jeringa1", 2, {
            ease: "circ.out",
            x: -310
        })
        .to("#jeringa2", 2, {
            ease: "circ.out",
            x: -280
        })
        .to("#mas", 2, {
            opacity: 100
        })
        .to(".vaccine", 1, {
            ease: "circ.out",
            y: -10
        })
        .to("#learn", 2, {
            opacity: 100
        })

    </script>

        
        <a class="prescribing" href=""><u>PRESCRIBING INFORMATION </u><i class="fas fa-angle-right"></i></a>

    <div class="scroll">
        <div class="scrollHere">
            <p>SCROLL HERE <i class="fas fa-caret-right"></i></p>
        </div>
        <p>
            <b>IMPORTANT SAFETY INFORMATION</b><br>
            •	SHINGRIX is contraindicated in anyone with a history of a severe allergic reaction (eg, anaphylaxis) to any component of the vaccine or after a previous dose of SHINGRIX<br>
            •	Review immunization history for possible vaccine sensitivity and previous vaccination-related adverse reactions. Appropriate medical treatment and supervision must be available to manage possible anaphylactic reactions following administration of SHINGRIX<br>
            •	Solicited local adverse reactions in subjects aged 50 years and older were pain (78.0%), redness (38.1%), and swelling (25.9%)<br>
            •	Solicited general adverse reactions in subjects aged 50 years and older were myalgia (44.7%), fatigue (44.5%), headache (37.7%), shivering (26.8%), fever (20.5%), and gastrointestinal symptoms (17.3%)<br>
            •	SHINGRIX was not studied in pregnant or lactating women, and it is unknown if it is excreted in human milk. Therefore, it cannot be established whether there is vaccine-associated risk with SHINGRIX in pregnant women or if there are effects on breastfed infants or milk production/excretion<br>
            •	Vaccination with SHINGRIX may not result in protection of all vaccine recipients<br>
            <br>
            <br>
            You are encouraged to report vaccine adverse events to the US Department of Health and Human Services. Visit <a href="">www.vaers.hhs.gov</a> to file a report, or call 1-800-822-7967.<br>
            <br>
            <br>
            This information is intended for US healthcare professionals only.<br>
            <br>
            <br>
            Trademarks owned or licensed by GSK<br>
            <br>
            <br>
            ©2018 GSK or licensor.<br>
            831155R0 October 2018
        </p>
    </div>

</body>
</html>